Johnson & Johnson’s consumer health unit Kenvue started trading. What it means for J&J shareholders like us

Kenvue Inc. Johnson & Johnson’s consumer-health business, trading information is displayed on a screen during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023.

Brendan Mcdermid | Reuters

Johnson & Johnson‘s (JNJ) consumer-health unit Kenvue (KVUE) soared more than 22% on its first day of trading Thursday, bringing the Club holding one step closer to completing its business separation. The planned split, which is set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations and the new pharma and medtech-focused J&J.

For all the latest health News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.